, Singapore

Parkway Life REIT DPU up 10.3% in Q2

Thanks to higher revenue and income from its properties.

Healthcare REIT Parkway Trust Management Limited (Parkway Life)'s distribution per unit (DPU) rose by 10.3% to 3.32 cents for Q2 this year.

According to the company's financial statement, the net property income increased 1.4% to $25.9m. Higher rent contribution from acquired properties and positive rental reversions contributed to the higher NPI.

The period also brought in a 1.1% revenue growth for the company.

Refinancing initiatives and yen depreciation, however, has pushed the group's finance cost savings down to $1.9m.

"Despite the growth of portfolio, finance costs have decreased mainly due to the finance cost savings arising from the refinancing initiatives completed in 2016 and in 1Q 2017 and depreciation of the Japanese Yen," the Parkway Life said.

Parkway Life owns a total of 49 properties in the Asia Pacific, including three hospitals in Singapore and 45 healthcare-related assets in Japan.

The company's portfolio size is at $1.7b as of the current time period.
 

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

DBS and OCBC expected to deliver steady Q1 net profits
Their net interest margins will ease as a result of their Hong Kong loans.
Singapore's maritime cluster navigates towards digital, green future
Adapting to emerging challenges, such as the adoption of alternative fuels, is deemed crucial for the country's maritime sector.
Shipping & Marine
SCG and A*STAR unveil joint labs for cellular immunotherapy enhancement
The partnership has a funding of nearly $30m supported under Singapore's Research, Innovation and Enterprise 2025 plan.
Healthcare